Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1046

Similar articles for PubMed (Select 9820990)

1.
3.

Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction.

Mark DB, Hlatky MA, Califf RM, Naylor CD, Lee KL, Armstrong PW, Barbash G, White H, Simoons ML, Nelson CL.

N Engl J Med. 1995 May 25;332(21):1418-24. Erratum in: N Engl J Med 1995 Jul 27;333(4):267.

4.

Alteplase: a pharmacoeconomic evaluation of its use in the management of myocardial infarction.

Barradell LB, Goa KL.

Pharmacoeconomics. 1995 Nov;8(5):428-59. Review.

PMID:
10172669
5.

Streptokinase. A pharmacoeconomic appraisal of its use in the management of acute myocardial infarction.

Gillis JC, Goa KL.

Pharmacoeconomics. 1996 Sep;10(3):281-310. Review.

PMID:
10163575
6.

A cost-effectiveness model of thrombolytic therapy for acute myocardial infarction.

Kalish SC, Gurwitz JH, Krumholz HM, Avorn J.

J Gen Intern Med. 1995 Jun;10(6):321-30.

PMID:
7562123
7.

Tissue plasminogen activator was cost-effective compared to streptokinase in only selected patients with acute myocardial infarction.

Kent DM, Vijan S, Hayward RA, Griffith JL, Beshansky JR, Selker HP.

J Clin Epidemiol. 2004 Aug;57(8):843-52.

PMID:
15485737
9.

Early thrombolysis for the treatment of acute myocardial infarction: a systematic review and economic evaluation.

Boland A, Dundar Y, Bagust A, Haycox A, Hill R, Mujica Mota R, Walley T, Dickson R.

Health Technol Assess. 2003;7(15):1-136. Review. No abstract available.

10.

New developments in thrombolytic therapy.

Collen D, Gold HK.

Adv Exp Med Biol. 1990;281:333-54. Review.

PMID:
2129372
11.

Holding GUSTO up to the light. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.

Lee KL, Califf RM, Simes J, Van de Werf F, Topol EJ.

Ann Intern Med. 1994 May 15;120(10):876-81; discussion 882-5.

PMID:
8154647
12.
13.

Pharmacoeconomic aspects of treatment of acute myocardial infarction with thrombolytic agents.

Woo KS, White HD.

Pharmacoeconomics. 1993 Mar;3(3):192-204. Review.

PMID:
10172049
16.

Bayesian cost-effectiveness analysis. An example using the GUSTO trial.

Fryback DG, Chinnis JO Jr, Ulvila JW.

Int J Technol Assess Health Care. 2001 Winter;17(1):83-97.

PMID:
11329847
17.
18.
19.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk